Is Methyldopa registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Methyldopa.

Is Methyldopa approved by the US FDA?

Drugs@FDA lists 47 application product lines for Methyldopa, including METHYLDOPA (Prescription); METHYLDOPA (Prescription); ALDOMET (Discontinued); ALDOMET (Discontinued); METHYLDOPA (Discontinued).

Is Methyldopa on the WHO Model List of Essential Medicines?

Yes — 12.3. Antihypertensive medicines (core list): Gestational hypertension.

Active substance

Methyldopa

SFDA 7
US FDA 47
Health Canada 3
NHS prices 3
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ALDOMET 250MG TABLETS	250 mg	Tablet · Oral use	30 Blister	SAR 18.35	Generic · Prescription	Algorithm SAL	Suspended
ALDOMET	250 mg	Tablet · Oral use	30 Blister	SAR 18.20	NCE · Prescription	MERCK SHARP & DOHME	Withdrawn by MAH · Not Marketed
ALDOMET	250 mg	Tablet · Oral use	100 Blister	SAR 52.80	Generic · Prescription	MERCK SHARP & DOHME	Withdrawn by MAH · Not Marketed
DOPAMET 250MG TABS	250 mg	Tablet · Oral use	100 Blister	SAR 76.85	Generic · Prescription	AXELLIA PHARMACEUTICALS	Withdrawn by MAH · Not Marketed
DOPAMET 250MG TABS	250 mg	Tablet · Oral use	24 Blister	SAR 21.00	Generic · Prescription	AXELLIA PHARMACEUTICALS	Withdrawn by MAH · Not Marketed
DOPANORE TAB 250 MG.	250 mg	Tablet · Oral use	30 Blister	SAR 5.20	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Withdrawn by MAH · Not Marketed
SEMBRINA TABLETS 250 MG.	250 mg	Tablet · Oral use	30 Blister	SAR 22.85	Generic · Prescription	ROCHE DIAGNOSTICS	Withdrawn by regulatory authority · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
METHYLDOPA	250MG	tablet · oral	MYLAN	Prescription	18 Apr 1985
METHYLDOPA	500MG; 250MG	tablet · oral	RISING	Prescription	18 Apr 1985
ALDOMET	250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	tablet · oral	MERCK	Discontinued	20 Dec 1962
ALDOMET	250MG/5ML	suspension · oral	MERCK	Discontinued	28 Aug 1981
METHYLDOPA	250MG; 500MG	tablet · oral	CHARTWELL RX	Discontinued	29 Jun 1984
METHYLDOPA	125MG	tablet · oral	ACCORD HLTHCARE	Discontinued	15 Oct 1985
METHYLDOPA	250MG	tablet · oral	ACCORD HLTHCARE	Discontinued	15 Oct 1985
METHYLDOPA	500MG	tablet · oral	ACCORD HLTHCARE	Discontinued	15 Oct 1985
METHYLDOPA	250MG	tablet · oral	HERITAGE PHARMA	Discontinued	20 Feb 1986
METHYLDOPA	500MG	tablet · oral	HERITAGE PHARMA	Discontinued	20 Feb 1986
METHYLDOPA	250MG	tablet · oral	PARKE DAVIS	Discontinued	15 Apr 1986
METHYLDOPA	500MG	tablet · oral	PARKE DAVIS	Discontinued	15 Apr 1986
METHYLDOPA	500MG	tablet · oral	WATSON LABS	Discontinued	6 Jun 1986
METHYLDOPA	250MG	tablet · oral	WATSON LABS	Discontinued	6 Jun 1986
METHYLDOPA	250MG	tablet · oral	SUN PHARM INDUSTRIES	Discontinued	9 Oct 1986
METHYLDOPA	125MG	tablet · oral	SUN PHARM INDUSTRIES	Discontinued	9 Oct 1986
METHYLDOPA	500MG	tablet · oral	SUN PHARM INDUSTRIES	Discontinued	9 Oct 1986
METHYLDOPA	250MG	tablet · oral	DURAMED PHARMS BARR	Discontinued	16 Dec 1986
METHYLDOPA	500MG	tablet · oral	DURAMED PHARMS BARR	Discontinued	16 Dec 1986
METHYLDOPA	125MG	tablet · oral	QUAGEN	Discontinued	2 Jan 1987
METHYLDOPA	250MG	tablet · oral	QUAGEN	Discontinued	2 Jan 1987
METHYLDOPA	500MG	tablet · oral	QUAGEN	Discontinued	2 Jan 1987
METHYLDOPA	125MG	tablet · oral	CHARTWELL RX	Discontinued	2 Mar 1988
METHYLDOPA	125MG	tablet · oral	PLIVA	Discontinued	7 Jul 1988
METHYLDOPA	250MG	tablet · oral	PLIVA	Discontinued	7 Jul 1988

22 more — full table

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
METHYLDOPA	00360252	125 MG	TABLET · ORAL	AA PHARMA INC
METHYLDOPA	00360260	250 MG	TABLET · ORAL	AA PHARMA INC
METHYLDOPA	00426830	500 MG	TABLET · ORAL	AA PHARMA INC

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Methyldopa 125mg tablets	£24.46	56 tablet	1 Oct 2026
NHS Drug Tariff	Methyldopa 250mg tablets	£5.47	56 tablet	1 Oct 2026
NHS Drug Tariff	Methyldopa 500mg tablets	£8.57	56 tablet	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

12.3. Antihypertensive medicines · core
Gestational hypertension
Oral > Solid: 250 mg

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.